Brief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
16/10/2026 12:33
BRIEF-Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer Oct 16 (Reuters) - Ironwood Pharmaceuticals, Inc. IRWD.O:
IRONWOOD PHARMACEUTICALS APPOINTS TAMMI GASKINS AS CHIEF EXECUTIVE OFFICER
IRONWOOD PHARMACEUTICALS - APPOINTS TAMMI GASKINS AS CEO EFFECTIVE JANUARY 1, 2027
IRONWOOD PHARMACEUTICALS - TOM MCCOURT TO RETIRE AS CEO ON JANUARY 1, 2027 AND REMAIN ON BOARD
Source text: ID:nBw92mP6Na
Further company coverage: IRWD.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ironwood Pharmaceuticals
See all newsBrief: Ironwood Pharmaceuticals Appoints Tammi Gaskins As Chief Executive Officer
Ironwood Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Ironwood Q2 revenue rises 33%
Brief: Ironwood Pharmaceuticals Repaid In Full $200 Million 1.5% Convertible Senior Notes Due 2026
Brief: FDA Approves Use Of Linzess In Pediatric Patients Aged 2 & Older With Functional Constipation